Skip to main content
logo
IGM Biosciences, Inc. (IGMS)
Au 14, 2025 - IGMS was delisted (reason: acquired by Concentra Biosciences)
1.270
-0.030 (-2.31%)
Inactive · Last trade price on Aug 13, 2025

IGM Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-53.39-195.8-246.42-221.1-165.16-81.36
Depreciation & Amortization
7.379.118.286.084.481.03
Loss (Gain) From Sale of Investments
-4.03-6.88-9.14-2.710.62-0.6
Stock-Based Compensation
30.1238.2746.5544.7125.878.45
Other Operating Activities
5.599.4115.1912.012.752.55
Change in Accounts Payable
-0.71-0.31-0.99-30.652.2
Change in Unearned Revenue
-145.05-2.68-2.13148.93--
Change in Income Taxes
-----0.04
Change in Other Net Operating Assets
-49.31-4.12-3.579.245.8-0.19
Operating Cash Flow
-156.51-153-192.23-5.85-124.98-67.88
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Capital Expenditures
-2.19-5.85-12.38-10.21-13.24-17.5
Sale of Property, Plant & Equipment
2.380.04----
Investment in Securities
118.0769.9780.74-215.4428.7175.79
Investing Cash Flow
118.2664.1668.36-225.6415.4658.29

Financing Activities

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Issuance of Common Stock
1.642.46115.07219.384.03216.51
Repurchase of Common Stock
--0---1.56-1.73
Other Financing Activities
--0.07----
Financing Cash Flow
1.642.39115.07219.382.48214.78

Net Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Cash Flow
-36.61-86.45-8.81-12.12-107.05205.19

Free Cash Flow

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Free Cash Flow
-158.7-158.85-204.61-16.06-138.23-85.38
Free Cash Flow Growth
------
Free Cash Flow Margin
-109.41%-5929.38%-9606.20%-1502.24%--
Free Cash Flow Per Share
-2.60-2.63-3.91-0.39-4.13-2.78
Levered Free Cash Flow
23.01-85.9-121.96-87.54-80.53-52.43
Unlevered Free Cash Flow
23.01-85.9-121.96-87.54-80.53-52.43

Additional Metrics

Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash Income Tax Paid
--0.63---
Change in Working Capital
-195.07-7.11-6.69155.176.452.05
SEC Filings: 10-K · 10-Q